Pharmacovigilance Services

In line with Abdulrehman Algosaibi G.T.C’s commitment to patient safety and regulatory excellence, the Pharmacovigilance (PV) Department was established in 2017 to ensure full compliance with the Saudi Food and Drug Authority (SFDA) Good Pharmacovigilance Practices. Since then, the PV Department has evolved into a specialized function overseeing the safety of all distributed products across the Kingdom. Today, our PV team delivers robust, end-to-end safety monitoring services that empower our partners with confidence and compliance. Through advanced systems, 24/7 safety oversight, and seamless coordination with multinational marketing authorization holders, we ensure every product entrusted to us is monitored with the utmost care. Our proactive, customer-focused PV service has become a key differentiator, reinforcing Algosaibi’s position as a trusted leader in the Saudi healthcare landscape.